Chengan Du

467 total citations
12 papers, 375 citations indexed

About

Chengan Du is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Chengan Du has authored 12 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Biomaterials and 3 papers in Oncology. Recurrent topics in Chengan Du's work include Nanoparticle-Based Drug Delivery (4 papers), Heat shock proteins research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Chengan Du is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Heat shock proteins research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Chengan Du collaborates with scholars based in United States and China. Chengan Du's co-authors include Feng Li, Huiyuan Wang, Ram I. Mahato, Yongzhuo Huang, Huixin Wang, Simone O. Heyliger, Marilyn D. Saulsbury, Hugh McLean, Janet L. Wolfe and Jeff Miller and has published in prestigious journals such as Cancer Research, Pharmaceutical Research and Molecular Pharmaceutics.

In The Last Decade

Chengan Du

11 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengan Du United States 6 193 134 75 71 39 12 375
María José Guillén Spain 11 164 0.8× 82 0.6× 53 0.7× 96 1.4× 55 1.4× 45 385
Guimin Xia China 12 231 1.2× 169 1.3× 124 1.7× 66 0.9× 93 2.4× 24 470
Anita Lalloo United States 8 168 0.9× 134 1.0× 88 1.2× 67 0.9× 39 1.0× 8 410
Vivek Makwana Australia 8 235 1.2× 85 0.6× 53 0.7× 42 0.6× 58 1.5× 10 436
Hui Fan China 9 171 0.9× 93 0.7× 37 0.5× 57 0.8× 51 1.3× 21 371
Otto Soepenberg Netherlands 9 184 1.0× 109 0.8× 43 0.6× 160 2.3× 35 0.9× 14 339
Kareem Ebeid United States 12 165 0.9× 74 0.6× 73 1.0× 46 0.6× 51 1.3× 21 347
Kuan-Boone Tan Singapore 8 218 1.1× 117 0.9× 79 1.1× 47 0.7× 17 0.4× 10 397
Vedagopuram Sreekanth India 15 401 2.1× 124 0.9× 61 0.8× 140 2.0× 95 2.4× 27 646
Kwok Shum United States 12 395 2.0× 144 1.1× 64 0.9× 109 1.5× 116 3.0× 15 656

Countries citing papers authored by Chengan Du

Since Specialization
Citations

This map shows the geographic impact of Chengan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengan Du more than expected).

Fields of papers citing papers by Chengan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengan Du. The network helps show where Chengan Du may publish in the future.

Co-authorship network of co-authors of Chengan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Chengan Du. A scholar is included among the top collaborators of Chengan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengan Du. Chengan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Du, Chengan, et al.. (2017). Lipid–Drug Conjugate for Enhancing Drug Delivery. Molecular Pharmaceutics. 14(5). 1325–1338. 240 indexed citations
3.
Li, Feng, et al.. (2016). Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles. Journal of Visualized Experiments. 20 indexed citations
4.
Li, Feng, et al.. (2015). Abstract 5538: A pH-responsive doxorubicin-lipid conjugate loaded nanomedicine for breast cancer treatment. Cancer Research. 75(15_Supplement). 5538–5538. 4 indexed citations
5.
Miller, Jeffrey D., et al.. (2014). In Vitro Metabolism of 3,4-Methylenedioxymethamphetamine in Human Hepatocytes. Journal of Analytical Toxicology. 38(5). 249–255. 5 indexed citations
6.
Du, Chengan, et al.. (2014). Compatibility of amiodarone hydrochloride with vasopressin during simulated Y-site administration.. PubMed. 17(5). 436–8. 1 indexed citations
7.
Wang, Huiyuan, Feng Li, Chengan Du, et al.. (2014). Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer. Molecular Pharmaceutics. 11(8). 2600–2611. 76 indexed citations
8.
Du, Chengan, et al.. (2005). High-performance liquid chromatography coupled with tandem mass spectrometry for the detection of amyloid Beta peptide related with Alzheimer's disease.. PubMed. 16(4). 356–63. 13 indexed citations
9.
Du, Chengan & Janet L. Wolfe. (2003). Kinetic study of recombinant human protein disulphide isomerase‐assisted C125A recombinant human interleukin‐2 folding. Biotechnology and Applied Biochemistry. 37(2). 129–138. 1 indexed citations
10.
Du, Chengan & Janet L. Wolfe. (2003). The Inhibition Mechanism of Guanidine Hydrochloride on the Catalytic Activity of Recombinant Human Protein Disulfide Isomerase. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(1). 47–53. 1 indexed citations
11.
Wolfe, Janet L., Laura Thoma, Chengan Du, et al.. (1999). Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection. American Journal of Health-System Pharmacy. 56(10). 985–989. 12 indexed citations
12.
Du, Chengan, et al.. (1998). Improved Folding Yields of a Model Protein Using Protein Disulfide Isomerase. Pharmaceutical Research. 15(12). 1808–1815. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026